Wei, X., Si, A., Zhao, S., Fu, Y., Li, J., Aishanjiang, K., . . . Wu, H. CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4–TGFα–EGFR signaling. BMC.
Chicago Style (17th ed.) CitationWei, Xindong, et al. CircUCK2(2,3) Promotes Cancer Progression and Enhances Synergistic Cytotoxicity of Lenvatinib with EGFR Inhibitors via Activating CNIH4–TGFα–EGFR Signaling. BMC.
MLA (9th ed.) CitationWei, Xindong, et al. CircUCK2(2,3) Promotes Cancer Progression and Enhances Synergistic Cytotoxicity of Lenvatinib with EGFR Inhibitors via Activating CNIH4–TGFα–EGFR Signaling. BMC.
Warning: These citations may not always be 100% accurate.